Implementing EO 14398 DEI discrimination gammagard
Active Purchase Order Awarded Last action
- Contract number
- 36C26027P0008
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value 0% obligated
- $58,250.92 Current and potential, with all options
- Completion date 4% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 |
About this award
Veterans Integrated Service Network 20 awarded a purchase order to Takeda Pharmaceuticals America, Inc. on October 1, 2026, for Gammagard (immune globulin) with a ceiling value of $58,250.92 and firm fixed price, with an ultimate completion date of September 30, 2027. Place of performance is Cambridge, Massachusetts. This order implements Executive Order 14398 addressing DEI discrimination. No set-aside was used.
Quick answers
Who was awarded contract 36C26027P0008?
36C26027P0008 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2026.
How much is contract 36C26027P0008 worth?
The government has obligated $0 on 36C26027P0008. Its current value, with exercised options, is $58,251.
Was contract 36C26027P0008 competed?
The extent of competition for 36C26027P0008 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award